Bariatric Surgery Improves Renal Function in Patients With Obesity

Area of Science:

• Nephrology
• Bariatric Surgery
• Metabolic Health

Background:

• Obesity impacts 93.3 million US adults, a key factor in chronic kidney disease (CKD) development and progression.
• Investigating weight loss interventions is crucial for managing obesity-related comorbidities like CKD.

Purpose of the Study:

• To examine the association between weight loss and renal function in patients undergoing bariatric surgery.
• To assess changes in secondary metabolic markers including hemoglobin A1c, lipids, glucose, and blood pressure.

Main Methods:

• Retrospective chart review of 55 participants in a 12-week community-based weight loss program prior to bariatric surgery (2009-2018).
• Primary outcome: association between weight loss and renal function (Glomerular Filtration Rate - GFR).
• Secondary outcomes: changes in HbA1c, lipids, fasting glucose, and blood pressure.

Main Results:

• Mean baseline GFR was 49 mL/min/m², with 80% female participants averaging 131 kg.
• One year post-intervention, 69% improved CKD stage (45% from stage 3A to 2), with GFR increasing by 15 mL/min/1.73m² (p=0.025).
• A negative correlation existed between weight and GFR (rs=-0.3556, p=0.013). Patients with hyperlipidemia saw a 12 mL/min/1.73m² GFR rise, while those without experienced a 24 mL/min/1.73m² rise (p=0.007).

Conclusions:

• Combined lifestyle intervention and bariatric surgery significantly improved renal function and reduced CKD progression.
• A comprehensive, multidisciplinary approach is vital for managing chronic kidney disease in obese populations.